Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 7 September 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 209 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 72 results:
Author Title [ Type(Desc)] Year
Filters: Author is Azoulay, L.  [Clear All Filters]
Journal Article
L. Azoulay, Eberg, M., Benayoun, S., and Pollak, M., 5alpha-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer, JAMA Oncol, vol. 1, pp. 314-20, 2015.
G. Simoneau, Moodie, E. E. M., Azoulay, L., and Platt, R. W., Adaptive Treatment Strategies with Survival Outcomes: An Application to the Treatment of Type 2 Diabetes using a Large Observational Database, Am J Epidemiol, 2020.
F. Lapi, Azoulay, L., Niazi, M. T., Yin, H., Benayoun, S., and Suissa, S., Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer, Jama, vol. 310, pp. 289-96, 2013.
A. J. Klil-Drori, Tascilar, K., Yin, H., Aprikian, A., Bitton, A., and Azoulay, L., Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer, Am J Epidemiol, vol. 184, pp. 15-22, 2016.
B. M. Hicks, Klil-Drori, A. J., Yin, H., Campeau, L., and Azoulay, L., Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer, Epidemiology, vol. 28, pp. 712-718, 2017.
J. Assayag, Yin, H., Benayoun, S., Pollak, M. N., Suissa, S., and Azoulay, L., Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer, Cancer Causes Control, vol. 24, pp. 839-45, 2013.
F. Khosrow-Khavar, Rej, S., Yin, H., Aprikian, A., and Azoulay, L., Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer, J Clin Oncol, vol. 35, pp. 201-207, 2017.
B. M. Hicks, Yin, H., Bladou, F., Ernst, P., and Azoulay, L., Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia, Thorax, vol. 72, pp. 596-597, 2017.
A. J. Klil-Drori, Yin, H., Tagalakis, V., Aprikian, A., and Azoulay, L., Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism, Eur Urol, vol. 70, pp. 56-61, 2016.
A. J. Klil-Drori, Santella, C., Tascilar, K., Yin, H., Aprikian, A., and Azoulay, L., Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study, Drug Saf, 2019.
L. Azoulay, Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., and Suissa, S., Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer, Eur Urol, vol. 60, pp. 1244-50, 2011.
B. M. Hicks, Filion, K. B., Yin, H., Sakr, L., Udell, J. A., and Azoulay, L., Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study, Bmj, vol. 363, p. k4209, 2018.
F. Khosrow-Khavar, Filion, K. B., Bouganim, N., Suissa, S., and Azoulay, L., Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study, Circulation, vol. 141, pp. 549-559, 2020.
F. Khosrow-Khavar, Yin, H., Barkun, A., Bouganim, N., and Azoulay, L., Aromatase inhibitors and the risk of colorectal cancer in postmenopausal women with breast cancer, Ann Oncol, vol. 29, pp. 744-748, 2018.
D. Abrahami, Renoux, C., Yin, H., Fournier, J. P., and Azoulay, L., The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation, Thromb Haemost, 2020.
J. L. Faillie, Yu, O. H., Yin, H., Hillaire-Buys, D., Barkun, A., and Azoulay, L., Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus, JAMA Intern Med, vol. 176, pp. 1474-1481, 2016.
S. Couraud, Dell'Aniello, S., Bouganim, N., and Azoulay, L., Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia, Breast Cancer Res Treat, vol. 146, pp. 619-26, 2014.
S. Couraud, Azoulay, L., Dell'Aniello, S., and Suissa, S., Cardiac glycosides use and the risk of lung cancer: a nested case-control study, BMC Cancer, vol. 14, p. 573, 2014.
F. Khosrow-Khavar, Bouganim, N., Filion, K. B., Suissa, S., and Azoulay, L., Cardiotoxicity of Sequential Aromatase Inhibitors Use in Women with Breast Cancer, Am J Epidemiol, 2020.
S. Y. Loo, Azoulay, L., Nie, R., Dell'Aniello, S., Yu, O. H. Y., and Renoux, C., Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study., Am J Med, 2019.
O. H. Yu, Yin, H., and Azoulay, L., The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death, Can J Diabetes, vol. 39, pp. 383-9, 2015.
L. Azoulay, Schneider-Lindner, V., Dell'Aniello, S., Schiffrin, A., and Suissa, S., Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study, Pharmacoepidemiol Drug Saf, vol. 19, pp. 335-42, 2010.
L. Azoulay, Dell'Aniello, S., Simon, T., Renoux, C., and Suissa, S., The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation, Thromb Haemost, vol. 109, pp. 431-9, 2013.
F. Lapi, Azoulay, L., Yin, H., Nessim, S. J., and Suissa, S., Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study, Bmj, vol. 346, p. e8525, 2013.
L. Azoulay, Dell'Aniello, S., Huiart, L., Fort, G. G. du, and Suissa, S., Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence, Breast Cancer Res Treat, vol. 126, pp. 695-703, 2011.
D. Abrahami, Douros, A., Yin, H., Yu, O. H. Y., Renoux, C., Bitton, A., and Azoulay, L., Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study, Bmj, vol. 360, p. k872, 2018.
A. Douros, Rouette, J., Yin, H., Yu, O. H. Y., Filion, K. B., and Azoulay, L., Dipeptidyl Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes, Diabetes Care, 2019.
J. L. Faillie, Filion, K. B., Patenaude, V., Ernst, P., and Azoulay, L., Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes, Diabetes Obes Metab, vol. 17, pp. 379-85, 2015.
A. Douros, Filion, K. B., Yin, H., Yu, O. H., Etminan, M., Udell, J. A., and Azoulay, L., Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy, Diabetes Care, vol. 41, pp. 2330-2338, 2018.
B. M. Hicks, Yin, H., Yu, O. H., Pollak, M. N., Platt, R. W., and Azoulay, L., Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink, Bmj, vol. 355, p. i5340, 2016.
I. Matok, Azoulay, L., Yin, H., and Suissa, S., Immortal time bias in observational studies of drug effects in pregnancy, Birth Defects Res A Clin Mol Teratol, vol. 100, pp. 658-62, 2014.
J. L. Faillie, Azoulay, L., Patenaude, V., Hillaire-Buys, D., and Suissa, S., Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study, Bmj, vol. 348, p. g2780, 2014.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study, Bmj, vol. 363, p. k4880, 2018.
J. Rouette, Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., and Azoulay, L., Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes, Diabet Med, 2020.
D. Abrahami, Yin, H., Yu, O. H. Y., Pollak, M. N., and Azoulay, L., Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes, Epidemiology, vol. 29, pp. 246-253, 2018.
O. H. Yu, Filion, K. B., Azoulay, L., Patenaude, V., Majdan, A., and Suissa, S., Incretin-based drugs and the risk of congestive heart failure, Diabetes Care, vol. 38, pp. 277-84, 2015.
L. Azoulay, Dell'Aniello, S., Simon, T. A., Renoux, C., and Suissa, S., Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes, Eur Heart J, vol. 35, pp. 1881-7, 2014.
I. Le Ray, Dell'Aniello, S., Bonnetain, F., Azoulay, L., and Suissa, S., Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study, Breast Cancer Res Treat, vol. 135, pp. 603-9, 2012.
S. Suissa, Azoulay, L., Dell'Aniello, S., Evans, M., Vora, J., and Pollak, M., Long-term effects of insulin glargine on the risk of breast cancer, Diabetologia, vol. 54, pp. 2254-62, 2011.
L. Azoulay, Assimes, T. L., Yin, H., Bartels, D. B., Schiffrin, E. L., and Suissa, S., Long-term use of angiotensin receptor blockers and the risk of cancer, PLoS One, vol. 7, p. e50893, 2012.
J. W. Wu, Azoulay, L., Majdan, A., Boivin, J. F., Pollak, M., and Suissa, S., Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes, J Clin Oncol, vol. 35, pp. 3647-3653, 2017.
J. P. Fournier, Yin, H., Yu, O. H., and Azoulay, L., Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus, Cmaj, vol. 186, pp. 1138-45, 2014.
L. Azoulay, Dell'Aniello, S., Gagnon, B., Pollak, M., and Suissa, S., Metformin and the incidence of prostate cancer in patients with type 2 diabetes, Cancer Epidemiol Biomarkers Prev, vol. 20, pp. 337-44, 2011.
B. M. Hicks, Yin, H., Sinyavskaya, L., Suissa, S., Azoulay, L., and Brassard, P., Metformin and the incidence of viral associated cancers in patients with type 2 diabetes, Int J Cancer, vol. 141, pp. 121-128, 2017.
K. B. Filion, Azoulay, L., Platt, R. W., Dahl, M., Dormuth, C. R., Clemens, K. K., Hu, N., Paterson, J. M., Targownik, L., Turin, T. C., Udell, J. A., and Ernst, P., A Multicenter Observational Study of Incretin-based Drugs and Heart Failure, N Engl J Med, vol. 374, pp. 1145-54, 2016.
L. Azoulay, Dell'Aniello, S., Simon, T. A., Langleben, D., Renoux, C., and Suissa, S., A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study, BMC Cardiovasc Disord, vol. 12, p. 49, 2012.
A. Douros, Yin, H., Yu, O. H. Y., Filion, K. B., Azoulay, L., and Suissa, S., Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events, Diabetes Care, vol. 40, pp. 1506-1513, 2017.
Y. Lian, Yin, H., Pollak, M. N., Carrier, S., Platt, R. W., Suissa, S., and Azoulay, L., Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer, Eur Urol, vol. 70, pp. 808-815, 2016.
M. Tuccori, Filion, K. B., Yin, H., Yu, O. H., Platt, R. W., and Azoulay, L., Pioglitazone use and risk of bladder cancer: population based cohort study, Bmj, vol. 352, p. i1541, 2016.
A. J. Klil-Drori, Yin, H., Abenhaim, H. A., Fort, G. G. du, and Azoulay, L., Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer, J Clin Psychiatry, vol. 78, pp. 714-719, 2017.
[Page last reviewed 7 September 2020]